Discoidin domain receptor 1 (DDR1), Drug repurposing, Virtual screening, molecular docking
Pan-FGFR inhibitors, covalent binding, 5-amino-1H-pyrazole-4-carboxamide, Gatekeeper mutation, structure-based drug design.